Cargando…

Faecal Calprotectin in Assessment of Mucosal Healing in Adults with Inflammatory Bowel Disease: A Meta-Analysis

Achieving mucosal healing in patients with inflammatory bowel disease is related to a higher incidence of sustained clinical remission and it translates to lower rates of hospitalisation and surgery. The assessment methods of disease activity and response to therapy are limited and mainly rely on co...

Descripción completa

Detalles Bibliográficos
Autores principales:	Bromke, Mariusz A., Neubauer, Katarzyna, Kempiński, Radosław, Krzystek-Korpacka, Małgorzata
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8161009/ https://www.ncbi.nlm.nih.gov/pubmed/34069684 http://dx.doi.org/10.3390/jcm10102203

Ejemplares similares

Biochemical Biomarkers of Mucosal Healing for Inflammatory Bowel Disease in Adults
por: Krzystek-Korpacka, Małgorzata, et al.
Publicado: (2020)

Oxidative Stress Markers in Inflammatory Bowel Diseases: Systematic Review
por: Krzystek-Korpacka, Małgorzata, et al.
Publicado: (2020)

Bile Acid Signaling in Inflammatory Bowel Disease
por: Bromke, Mariusz A., et al.
Publicado: (2021)

Systemic interleukin-9 in inflammatory bowel disease: Association with mucosal healing in ulcerative colitis
por: Matusiewicz, Malgorzata, et al.
Publicado: (2017)

Transcriptional and Metabolomic Analysis of L-Arginine/Nitric Oxide Pathway in Inflammatory Bowel Disease and Its Association with Local Inflammatory and Angiogenic Response: Preliminary Findings
por: Krzystek-Korpacka, Małgorzata, et al.
Publicado: (2020)

Nonenzymatic Serum Antioxidant Capacity in IBD and Its Association with the Severity of Bowel Inflammation and Corticosteroids Treatment
por: Neubauer, Katarzyna, et al.
Publicado: (2019)

Reduced Transferrin Levels in Active Inflammatory Bowel Disease
por: Matusiewicz, Malgorzata, et al.
Publicado: (2017)

Peripheral Lymphocytes of Patients with Inflammatory Bowel Disease Have Altered Concentrations of Key Apoptosis Players: Preliminary Results
por: Neubauer, Katarzyna, et al.
Publicado: (2018)

The level of faecal calprotectin as a noninvasive biomarker of mucosal healing in children with ulcerative colitis
por: Szymańska, Edyta, et al.
Publicado: (2020)

Matrix Metalloproteinase-9: Its Interplay with Angiogenic Factors in Inflammatory Bowel Diseases
por: Matusiewicz, Malgorzata, et al.
Publicado: (2014)

Measurement of faecal calprotectin and lactoferrin in inflammatory bowel disease
por: Lamb, C A, et al.
Publicado: (2011)

Faecal calprotectin for screening of patients with suspected inflammatory bowel disease: diagnostic meta-analysis
por: van Rheenen, Patrick F, et al.
Publicado: (2010)

Ultrasound Elastography in the Assessment of the Intestinal Changes in Inflammatory Bowel Disease—Systematic Review
por: Ślósarz, Dominika, et al.
Publicado: (2021)

Usefulness of Faecal Calprotectin Measurement in Children with Various Types of Inflammatory Bowel Disease
por: Komraus, Marzena, et al.
Publicado: (2012)

Oversecretion and Overexpression of Nicotinamide Phosphoribosyltransferase/Pre-B Colony-Enhancing Factor/Visfatin in Inflammatory Bowel Disease Reflects the Disease Activity, Severity of Inflammatory Response and Hypoxia
por: Neubauer, Katarzyna, et al.
Publicado: (2019)

Does faecal calprotectin differentiate between inflammatory bowel disease colitis and non-inflammatory bowel disease colitides?
por: Khalil, Ahmed F., et al.
Publicado: (2020)

Faecal haemoglobin and faecal calprotectin as indicators of bowel disease in patients presenting to primary care with bowel symptoms
por: Mowat, Craig, et al.
Publicado: (2016)

Cost-effectiveness of faecal calprotectin used in primary care in the diagnosis of inflammatory bowel disease
por: Zhang, Wei, et al.
Publicado: (2019)

Faecal calprotectin to detect inflammatory bowel disease: a systematic review and exploratory meta-analysis of test accuracy
por: Freeman, Karoline, et al.
Publicado: (2019)

L-Arginine/Nitric Oxide Pathway Is Altered in Colorectal Cancer and Can Be Modulated by Novel Derivatives from Oxicam Class of Non-Steroidal Anti-Inflammatory Drugs
por: Krzystek-Korpacka, Małgorzata, et al.
Publicado: (2020)

Utility of faecal calprotectin in inflammatory bowel disease (IBD): what cut-offs should we apply?
por: Dhaliwal, A, et al.
Publicado: (2015)

Fecal calprotectin measurement is a marker of short-term clinical outcome and presence of mucosal healing in patients with inflammatory bowel disease
por: Kostas, Athanasios, et al.
Publicado: (2017)

Calprotectin in inflammatory bowel disease
por: Khaki-Khatibi, Fatemeh, et al.
Publicado: (2020)

Inflammatory bowel disease induced by bimekizumab
por: Wietrzykowska-Grishanovich, Dominika, et al.
Publicado: (2022)

Point-of-care faecal calprotectin testing in patients with paediatric inflammatory bowel disease during the COVID-19 pandemic
por: Jere, Mwansa, et al.
Publicado: (2021)

Fecal calprotectin in inflammatory bowel disease
por: Walsham, Natalie E, et al.
Publicado: (2016)

Faecal calprotectin concentration in children with coeliac disease
por: Szaflarska-Popławska, Anna, et al.
Publicado: (2020)

Guidance on the interpretation of faecal calprotectin levels in children
por: Orfei, Martina, et al.
Publicado: (2021)

Test accuracy of faecal calprotectin for inflammatory bowel disease in UK primary care: a retrospective cohort study of the THIN data
por: Freeman, Karoline, et al.
Publicado: (2021)

Diagnostic Potential of Systemic Eosinophil-Associated Cytokines and Growth Factors in IBD
por: Neubauer, Katarzyna, et al.
Publicado: (2018)

Clinical Value of Fecal Calprotectin in Predicting Mucosal Healing in Patients With Ulcerative Colitis
por: Chen, Fang, et al.
Publicado: (2021)

Faecal calprotectin indicates intestinal inflammation in COVID-19
por: Effenberger, Maria, et al.
Publicado: (2020)

Gastrointestinal manifestations and their relation to faecal calprotectin in children with autism
por: Azouz, Hanan Galal, et al.
Publicado: (2021)

Faecal calprotectin in COVID-19 patients with intestinal symptoms
por: Ellakany, Walid Ismail, et al.
Publicado: (2022)

Lean mass, magnesium, faecal calprotectin and glucocorticoid exposure as risk factors for low bone mineral density in inflammatory bowel disease patients
por: Soare, Iulia, et al.
Publicado: (2021)

L-Arginine/NO Pathway Metabolites in Colorectal Cancer: Relevance as Disease Biomarkers and Predictors of Adverse Clinical Outcomes Following Surgery
por: Bednarz-Misa, Iwona, et al.
Publicado: (2020)

Nampt/PBEF/Visfatin Upregulation in Colorectal Tumors, Mirrored in Normal Tissue and Whole Blood of Colorectal Cancer Patients, Is Associated with Metastasis, Hypoxia, IL1β, and Anemia
por: Neubauer, Katarzyna, et al.
Publicado: (2015)

The Role of Fecal Calprotectin in Investigating Inflammatory Bowel Diseases
por: Erbayrak, Mustafa, et al.
Publicado: (2009)

Fecal Calprotectin for the Diagnosis and Management of Inflammatory Bowel Diseases
por: Kapel, Nathalie, et al.
Publicado: (2023)

Calprotectin, Biomarker of Depression in Patients with Inflammatory Bowel Disease?
por: Iordache, Miorita Melina, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_mt5qfk45ei9sur7ilhuuitd6pe